Literature DB >> 20813914

Role of EP4 receptor and prostaglandin transporter in prostaglandin E2-induced alteration in colonic epithelial barrier integrity.

Manigandan Lejeune1, Pearl Leung, Paul L Beck, Kris Chadee.   

Abstract

Prostaglandin E(2) (PGE(2)) is a proinflammatory lipid mediator produced in excess in inflammatory bowel disease (IBD). PGE(2) couples to and signals via four different E-prostanoid (EP) receptors, namely EP1, EP2, EP3, and EP4. In this study, we determined a role for PGE(2) and EP4 receptors in altering colonic epithelial barrier integrity. In healthy colonic mucosa, EP4 receptors were localized on apical plasma membrane of epithelial cells at the tip of mucosal folds, whereas, in patients with IBD and in rats with dextran sodium sulfate (DSS)-induced colitis, they were diffusely overexpressed throughout the mucosa. Similarly, expression of EP4 receptor was polarized in T84 colonic epithelial monolayer and mimics the normal epithelium. Apical exposure of T84 monolayer with high levels of PGE(2) decreased barrier integrity, which was abrogated by an EP4 receptor antagonist. To reveal the mechanism of vectorial transport of basally produced PGE(2) toward apical EP4 receptors, we identified prostaglandin transporters (PGT) in human colonic epithelia. PGT were least expressed on epithelial cells at the colonic mucosal folds of control subjects but overexpressed in epithelial cells of patients with IBD or animals with DSS-induced colitis. T84 monolayer also expressed PGT, which increased twofold following stimulation with TNF-α. Importantly, in T84 monolayer stimulated with TNF-α, there was a corresponding increase in the uptake and vectorial transport of (3)H-PGE(2) to the apical surface. Knockdown or pharmacological inhibition of PGT significantly decreased vectorial transport of (3)H-PGE(2). These studies unravel a mechanism whereby EP4 receptor and PGT play a role in PGE(2)-induced alteration of epithelial barrier integrity in colitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813914     DOI: 10.1152/ajpgi.00280.2010

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  12 in total

1.  Prostaglandin E2 produced by Entamoeba histolytica signals via EP4 receptor and alters claudin-4 to increase ion permeability of tight junctions.

Authors:  Manigandan Lejeune; France Moreau; Kris Chadee
Journal:  Am J Pathol       Date:  2011-05-31       Impact factor: 4.307

Review 2.  Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂.

Authors:  Jessica K Norberg; Earlphia Sells; Hui-Hua Chang; Srinivas R Alla; Shuxing Zhang; Emmanuelle J Meuillet
Journal:  Pharm Pat Anal       Date:  2013-03

3.  IBD candidate genes and intestinal barrier regulation.

Authors:  Declan F McCole
Journal:  Inflamm Bowel Dis       Date:  2014-10       Impact factor: 5.325

4.  NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations.

Authors:  Leanne Mortimer; France Moreau; Justin A MacDonald; Kris Chadee
Journal:  Nat Immunol       Date:  2016-08-22       Impact factor: 25.606

Review 5.  Isoflavones and inflammatory bowel disease.

Authors:  Ze-Yu Wu; Li-Xuan Sang; Bing Chang
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

Review 6.  Involvement of the gut chemosensory system in the regulation of colonic anion secretion.

Authors:  A Kuwahara
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

7.  Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis.

Authors:  Scott S Short; Jin Wang; Shannon L Castle; G Esteban Fernandez; Nancy Smiley; Michael Zobel; Elizabeth M Pontarelli; Stephanie C Papillon; Anatoly V Grishin; Henri R Ford
Journal:  Lab Invest       Date:  2013-10-14       Impact factor: 5.662

8.  Cellular density-dependent down-regulation of EP4 prostanoid receptors via the up-regulation of hypoxia-inducible factor-1α in HCA-7 human colon cancer cells.

Authors:  Sho Otake; Kenji Yoshida; Naofumi Seira; Christopher M Sanchez; John W Regan; Hiromichi Fujino; Toshihiko Murayama
Journal:  Pharmacol Res Perspect       Date:  2014-11-07

9.  Salvianolic Acid B Restored Impaired Barrier Function via Downregulation of MLCK by microRNA-1 in Rat Colitis Model.

Authors:  Yongjian Xiong; Jingyu Wang; Hongwei Chu; Dapeng Chen; Huishu Guo
Journal:  Front Pharmacol       Date:  2016-05-26       Impact factor: 5.810

10.  Lymphocytic colitis is associated with increased pro-inflammatory cytokine profile and up regulation of prostaglandin receptor EP4.

Authors:  Indranil Dey; Paul L Beck; Kris Chadee
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.